Psychedelic medicine has moved in a few years from the margins of oncology and psychiatry into serious clinical research. In Naturally Divine: A Catalyst for Body, Mind and Planet, Lucas Pawlik steps into that space with a compact, research-oriented book that tries to answer three linked questions. What does psilocybin actually do in the mind and brain. Under what conditions does it have lasting therapeutic impact. And how might those individual shifts matter for society and global health.

Pawlik’s central claim is clear. The lasting benefits reported in modern psilocybin studies do not arise from drug exposure alone. They are closely tied to what researchers call a “mystical-type experience.” In simple terms, this means a brief but profound state marked by unity, sacredness, a sense of insight or “knowing,” and a positive emotional tone. The book leans on the well known Mystical Experience Questionnaire (MEQ 30) that has been used in clinical trials at institutions such as Johns Hopkins and NYU to quantify this pattern. When that kind of experience occurs, long term improvements in depression, anxiety, addiction or existential distress are much more likely. When it does not, the therapeutic impact is often modest or fleeting.

This is especially relevant in cancer care. Pawlik reviews trials in patients with advanced or life threatening cancer who received psilocybin under controlled conditions. In these studies, a single guided session could markedly reduce depression and death anxiety and improve quality of life for months. The key predictor of durable benefit was the intensity of the mystical experience. For readers of Townsend Letter who work with patients facing serious illness, this link between inner experience and clinical outcome will feel both familiar and provocative. It suggests that the “set and setting” so often discussed in psychedelic circles are not secondary. They are central to whether psilocybin is a powerful tool or simply a passing altered state.

The second distinctive feature of Naturally Divine is its attempt to organize the therapeutic landscape in a way that is actually usable. The back of the book reads almost like a mini-monograph. Tables summarize research on psilocybin across addictive disorders, depression, anxiety, post-traumatic stress, obsessive-compulsive disorder, substance use, and the distress that accompanies terminal illness. Other tables list key neurobiological findings, including work on neuroplasticity, network desynchronization and modulation of the default mode network. For busy clinicians, this kind of concise, referenced overview is often more valuable than yet another popular essay on “magic mushrooms.”

Importantly, the book is not a promotional tract. A substantial section is devoted to risks, contraindications and drug interactions. Pawlik reviews acute physical side effects such as elevations in blood pressure and heart rate, as well as psychological risks including fear, paranoia and difficult or destabilizing sessions. He is explicit that psilocybin is inappropriate for people with psychotic disorders or certain cardiovascular conditions, and that antidepressants and other serotonergic agents introduce real interaction risks. There is also practical guidance on screening, preparation, supervision, emergency protocols and the need for careful integration afterward. For a general audience, this will help counter the idea that psilocybin is either a cure-all or a casual wellness tool.

The third strand, and perhaps the most original, is the discussion of artificial intelligence as a support for psychedelic work. Pawlik describes how large language models can be used to analyze first person reports of psilocybin experiences and score them against the MEQ 30. In other words, a narrative of a “trip” can be converted into a structured profile of mystical-experience features. He argues that this kind of AI assisted analysis can help people who have taken psilocybin outside of a formal clinical setting understand whether their experience reached the levels of depth that correlate with lasting therapeutic benefit. It can also support research by making it easier to process large numbers of qualitative reports.

There are obvious caveats. AI tools are only as good as their training and prompts, and they do not replace careful clinical assessment or integration. Pawlik acknowledges this and frames AI not as a new authority, but as a way to bridge the gap between subjective experience and the quantitative tools used in research.

Finally, Naturally Divine situates psilocybin within a wider public health and sustainability frame. Pawlik links individual changes observed after meaningful psychedelic experiences, such as increased empathy, reduced rigid thinking and greater ecological concern, to broader social outcomes. He discusses the United Nations Sustainable Development Goals and suggests that inner shifts in values and perception may be a missing ingredient in efforts to address global crises in mental health and environmental degradation. Readers may or may not agree with the breadth of this argument, but it is a serious attempt to connect personal healing with collective health.

Who is this book for? It is not a how-to manual for self medication, nor a grower’s guide or lifestyle book. The natural audience is clinicians, therapists and health professionals who want a coherent overview of psilocybin research, with particular attention to mystical experience and end-of-life distress. It will also appeal to educated lay readers who are comfortable with scientific references and who want to understand both the promise and limits of this emerging field.

For Townsend Letter readers, the value of Naturally Divine lies in its combination of rigor and breadth. It brings together clinical data, spiritual phenomenology, neurobiology, risk analysis and even AI, while keeping a steady focus on what matters most. Can psilocybin, under the right conditions, help relieve suffering in conditions such as cancer, depression and addiction, and what would it mean if that kind of inner transformation became more widely available. Pawlik does not claim to have all the answers, but he provides a thoughtful, well referenced starting point for those who want to explore these questions in depth.

Find the book and learn more about the Mycoverse Foundation here: https://mycoverse-foundation.org/produkt/buch-naturally-divine

About the Author – Lucas Pawlik, PhD

Dr. Lucas Pawlik is an Austrian philosopher, systems scientist, and ethics advisor whose work focuses on mystical experience, consciousness, and the ethics of science and technology. He has a background in philosophy, cybernetics, and movement science, and has taught in transdisciplinary education programs, including a university course on “PROvocative Pedagogy.”  As ethics advisor to the Mycoverse Foundation, he works on bioethics, psychedelic medicine, AI policy, and planetary sustainability, with a particular interest in how fungi and altered states of consciousness can support human and ecological resilience. 

About the Mycoverse Foundation

The Mycoverse Foundation is a non-profit foundation based in Vaduz, Liechtenstein, dedicated to research, education, and innovation around fungi.  Its mission is to collect, create, and share expert knowledge on mushrooms and mycological applications, from medicinal and nutritional uses to soil regeneration, bioremediation, and sustainable materials. The foundation supports interdisciplinary research, works on quality standards for mushroom-based products, and promotes mycotherapy and fungal science as tools for human, animal, and planetary health, in line with several UN Sustainable Development Goals.